Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Saved in:
| Title: | Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease. |
|---|---|
| Authors: | Honig, Lawrence S.1 (AUTHOR) lh456@cumc.columbia.edu, Sabbagh, Marwan N.2 (AUTHOR), van Dyck, Christopher H.3 (AUTHOR), Sperling, Reisa A.4 (AUTHOR), Hersch, Steven5 (AUTHOR), Matta, Andre5 (AUTHOR), Giorgi, Luigi6 (AUTHOR), Gee, Michelle6 (AUTHOR), Kanekiyo, Michio5 (AUTHOR), Li, David5 (AUTHOR), Purcell, Derk7 (AUTHOR), Dhadda, Shobha5 (AUTHOR), Irizarry, Michael5 (AUTHOR), Kramer, Lynn5 (AUTHOR) |
| Source: | Alzheimer's Research & Therapy. 7/10/2024, Vol. 16 Issue 1, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
